These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 3274208)
21. The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus. Sthoeger Z; Sthoeger D; Green L; Geltner D J Rheumatol; 1993 Dec; 20(12):2058-61. PubMed ID: 8014933 [TBL] [Abstract][Full Text] [Related]
22. The "primary" antiphospholipid syndrome: major clinical and serological features. Asherson RA; Khamashta MA; Ordi-Ros J; Derksen RH; Machin SJ; Barquinero J; Outt HH; Harris EN; Vilardell-Torres M; Hughes GR Medicine (Baltimore); 1989 Nov; 68(6):366-74. PubMed ID: 2509856 [TBL] [Abstract][Full Text] [Related]
23. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Kumar S; Benseler SM; Kirby-Allen M; Silverman ED Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962 [TBL] [Abstract][Full Text] [Related]
24. [Antiphospholipid antibodies, thrombosis and lupus disease. Value of the assay of anticardiolipin antibodies by the ELISA technic]. Meyer O; Cyna L; Borda-Iriarte O; Jungers P; Piette JC; Dautzenberg MD; Dupuy E; Ryckewaert A Rev Rhum Mal Osteoartic; 1985 May; 52(5):297-305. PubMed ID: 3874416 [TBL] [Abstract][Full Text] [Related]
25. [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis]. Zea Mendoza A; Rodríguez García A; Irigoyen Oyarzábal MV; Vázquez Díaz M; Pardo Vigo A; Mampaso FM; Ortuño Mirete J Med Clin (Barc); 1989 May; 92(19):724-8. PubMed ID: 2502695 [TBL] [Abstract][Full Text] [Related]
27. Significance of autoimmune haemolytic anaemia and immune thrombocytopenia (Evans' syndrome) in systemic lupus erythematosus. Pasangna J; Lim CB; Duraisamy G; Lajin I Malays J Pathol; 1994 Jun; 16(1):79-82. PubMed ID: 16329581 [TBL] [Abstract][Full Text] [Related]
28. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [TBL] [Abstract][Full Text] [Related]
29. [Antiphospholipid antibodies: clinical significance in systemic lupus erythematosus]. Zhou DC; Dong Y; Pan JQ Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):78-80, 125. PubMed ID: 2500316 [TBL] [Abstract][Full Text] [Related]
30. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222 [TBL] [Abstract][Full Text] [Related]
31. [Antibodies to anticoagulants in rheumatic autoimmune diseases]. Gromnica-Ihle E; Schössler W; Franz J; Ziemer S; Hüge H; Apostoloff E Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):549-56. PubMed ID: 1714859 [TBL] [Abstract][Full Text] [Related]
33. Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans' syndrome. Cervera H; Jara LJ; Pizarro S; Enkerlin HL; Fernandez M; Medina F; Fraga A; Miranda JM J Rheumatol; 1995 Oct; 22(10):1867-71. PubMed ID: 8991983 [TBL] [Abstract][Full Text] [Related]
34. [The antiphospholipid syndrome in patients with systemic lupus erythematosus and in their closest blood relatives (a preliminary report)]. Sapsova E; Tsvetkova T; Ledzhev I; Terzieva D Vutr Boles; 1990; 29(5):96-9. PubMed ID: 2127871 [TBL] [Abstract][Full Text] [Related]
35. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies. Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980 [TBL] [Abstract][Full Text] [Related]
36. Anticardiolipin and complement activation: relation to clinical symptoms. Norberg R; Nived O; Sturfelt G; Unander M; Arfors L J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():149-53. PubMed ID: 3612644 [TBL] [Abstract][Full Text] [Related]
37. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Long AA; Ginsberg JS; Brill-Edwards P; Johnston M; Turner C; Denburg JA; Bensen WG; Cividino A; Andrew M; Hirsh J Thromb Haemost; 1991 Nov; 66(5):520-4. PubMed ID: 1803614 [TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
39. Evans' syndrome with splenic periarterial fibrosis but no serologic evidence of systemic lupus erythematosus. Kabbash LG; Duguid WP; Whittemore NB; Gold P Can Med Assoc J; 1981 Dec; 125(11):1253-4. PubMed ID: 7199368 [No Abstract] [Full Text] [Related]
40. Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Koike T; Sueishi M; Funaki H; Tomioka H; Yoshida S Clin Exp Immunol; 1984 Apr; 56(1):193-9. PubMed ID: 6201309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]